Boston Scientific | BSX - Ordinary Share Capital



Boston Scientific reported $17M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
Abbott USD 25.12B 28M Mar/2025
AtriCure USD 49.69M 49.64M Jun/2025
Avanos Medical USD 46.31M 45.81M Jun/2025
Baxter International USD 683M 0 Dec/2024
Becton, Dickinson and Co. USD 370.59M 406K Jun/2025
Boston Scientific USD 17M 0 Mar/2025
CONMED USD 30.95M 30.63M Jun/2025
Cooper Companies USD 198.8M 177M Jul/2025
Danaher USD 715.9M 706.9M Jun/2025
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 654.8M 500K Dec/2024
Globus Medical USD 135.05M 134.92M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Illumina USD 154M 152M Jun/2025
Insulet USD 70.39M 70.29M Jun/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 358.42M 358.02M Jun/2025
J&J USD 3.12B 0 Mar/2025
Masimo USD 54.3M 54.2M Jun/2025
Medtronic USD 128K 128K Apr/2025
Merit Medical Systems USD 59.22M 658.89M Jun/2025
Stryker USD 382.3M 344.3M Jun/2025
Tandem Diabetes Care USD 67.53M 67.46M Jun/2025
Teleflex USD 44.19M 4M Jun/2025
Zimmer Biomet Holdings USD 197.9M 194.7M Jun/2025